Clinical trials: Post-surgical Ocular Inflammation

Pterygium, Ocular Pain

Efficacy and Safety of PRO-155 on Inflammation of the Conjunctival Surface in Subjects With Grade I-III Pterygium vs Placebo.

• Completed
• Age: 18 to 90 years
• Phase 4
• Results posted

Title of the study Efficacy and safety of PRO-155 (Zebesten ofteno®) on inflammation of the conjunctival surface in subjects with grade I-III pterygium vs placebo. Hypothesis H0.

Conditions

Pterygium, Ocular Pain, Ocular Inflammation, Post-surgical Inflammation

Trial name

PRO-155/IV (NCT03521791)

Testing

PRO-155

Where

3 sites in Mexico

Volunteers

166 people

Sponsor

Laboratorios Sophia S.A de C.V.